IPHA Competitors & Alternatives
Compare Innate Pharma with similar stocks in the same industry
Biotechnology
IPHA
Main Stock$1.41
Tradestie Score
52
Market Cap
$182.31M
Revenue Growth
-0.5%
Analyst Upside
+325.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$5.01
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.93
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$24.02
|
$180.53M | - | 45 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$21.57
|
$170.45M | - | 57 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.37
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.26
|
$110.20M | - | 52 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$40.24
|
$76.55M | - | 63 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$1.49
|
$72.18M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.32
|
$71.69M | - | 60 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.75
|
$67.94M | - | 55 | Compare |
More IPHA Analysis
Data updated: May 09, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry